Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IvIg in Post-Polio Syndrome
NCT00231439Phase 3Completed
- Sponsor
- Haukeland University Hospital
- Start
- Aug 2003
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in post-polio syndrome (PPS) comparing IvIg with Placebo (2 arms). Primary endpoints: Pain intensity at 3 months, Fatigue level at 3 months and 1 more. Started Aug 2003; status: completed.
02
Drugs
immune globulin
03
Conditions
post-polio syndrome (PPS)
Beyond the preview
Go deeper on NCT00231439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231439.